Product Information

KEVZARA 200 MG/1.14 ML PEN INJ is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $2072.9399 per ML under NDC 00024592201. Its NADAC has been published 131 times since May 22, 2024.

KEVZARA 200 MG/1.14 ML PEN INJ

sarilumab
$2072.9399per ML

Strength

200 mg/1.14mL

NDC

00024592201

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

SARILUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761037

On Market Since

5/22/2017

Pharmacological Classes

Interleukin 6 Receptor Antagonists
Interleukin-6 Receptor Antagonist

Price Statistics

The NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has been published 131 times since May 22, 2024, and over the history we have for it it has risen 11.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2072.9399 per ML
All-time high$2082.1048 (Jun 10, 2026)
All-time low$1845.7572 (Jul 17, 2024)
52-week high$2082.1048
52-week low$1961.8673
Median price$1962.0944
Average price$1973.8493
Largest weekly change+6.0% (Jan 8, 2025)
Weeks tracked131
Tracking sinceMay 22, 2024

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.4%

1Y

+5.7%

3Y

N/A

5Y

N/A

All

+11.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KEVZARA 200 MG/1.14 ML PEN INJ?

The current National Average Drug Acquisition Cost (NADAC) for KEVZARA 200 MG/1.14 ML PEN INJ, manufactured by Sanofi-Aventis U.S. LLC, is $2072.9399 per ML (NDC 00024592201), effective Nov 18, 2026.

How has the price of KEVZARA 200 MG/1.14 ML PEN INJ changed over time?

Over the history we have for it, the NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has risen 11.9%. It has been tracked across 131 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for KEVZARA 200 MG/1.14 ML PEN INJ?

Since May 22, 2024, the NADAC for KEVZARA 200 MG/1.14 ML PEN INJ has ranged from a low of $1845.7572 (Jul 17, 2024) to a high of $2082.1048 (Jun 10, 2026), with a median of $1962.0944 per ML.

Are there cheaper alternatives to KEVZARA 200 MG/1.14 ML PEN INJ?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KEVZARA 200 MG/1.14 ML PEN INJ in a comparable dosage form, but none are currently priced below it.

Who manufactures KEVZARA 200 MG/1.14 ML PEN INJ?

KEVZARA 200 MG/1.14 ML PEN INJ (NDC 00024592201) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.